Pick Disease of the Brain clinical trials
The registry lists 104 studies for Pick Disease of the Brain across more than 10 countries. 32 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-17.
Get an email when these change. Save the Pick Disease of the Brain studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Status
Who runs them
University of California, San Francisco (5) · University of Southern California (5) · University of Pennsylvania (4) · Axon Neuroscience SE (3) · National Institute of Neurological Disorders and Stroke (NINDS) (3) · Novartis Pharmaceuticals (3) · University of California, Los Angeles (2) · Mayo Clinic (2)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 9
- Dec 2026The Skin as a Window to the Central Nervous System in Frontotempolar Lombar Degeneration · Nantes University Hospital
- Jan 2027Tau PET in Imaging and Cognition: Healthy Adults From 55-90 · Yaakov Stern
- Jan 2027Longitudinal Early-onset Alzheimer's Disease Study Protocol · Indiana University
- Mar 2027Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia · University Hospital, Toulouse
- Apr 2027Study of Tau Imaging With the Use of [18F]MK-6240 Tracer · Tammie L. S. Benzinger, MD, PhD
- Jul 2027Alzheimer's Disease Neuroimaging Initiative 4 · University of Southern California
- Aug 2027Investigator Initiated Study for the Safety and Efficacy in Frontotemporal Dementia · Hee-Jin Kim
- Aug 2027Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive Impairment · University Hospital, Geneva
- Nov 2027Tau PET/CT in Various Tau-Related Disease Patients · Tianjin Medical University
Who these studies take
Of the 20 Pick Disease of the Brain studies recruiting now, 8 (40%) set no upper age limit and 2 (10%) stop at 75 or younger. 1 (5%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 12 (60%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (5%) | 1 (5%) |
| 18 | 6 (30%) | 6 (30%) |
| 30 | 8 (40%) | 8 (40%) |
| 40 | 9 (45%) | 9 (45%) |
| 50 | 17 (85%) | 17 (85%) |
| 65 | 20 (100%) | 20 (100%) |
| 75 | 19 (95%) | 19 (95%) |
| 85 | 14 (70%) | 14 (70%) |
Across all 104 studies, recruiting or not: 13% stop at 75 or younger and 5% at 65; 5% take children; 0% are for women only and 1% for men only; 46% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 20, 2026.
Stopped1
- A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 GenesTerminatedOct 29, 2026NCT04747431
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 104. Browse all 104 → or search them.
- Ultra-high-performance Positron Emission Tomography (PET) of Synaptic Density, Reactive Astrogliosis and Tau in Alzheimer's DiseaseNot yet recruitingNCT079060541 country
- A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's DiseaseRecruitingNCT06297590Phase 13 countries
- Alzheimer's Tau Platform: Regimen A - AADvac1Enrolling by invitationNCT07167966Phase 21 country
- A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear PalsyRecruitingNCT07498426Phase 312 countries
- A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Primary TauopathiesNot yet recruitingNCT07868328Phase 2
- Restoring Cervical Lymphatic Drainage in Alzheimer's DiseaseRecruitingNCT07854327Not applicable1 country
- Alzheimer's Disease Neuroimaging Initiative 4Enrolling by invitationNCT056170142 countries
- A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.RecruitingNCT06823752Phase 21 country
- Tau PET/CT in Various Tau-Related Disease PatientsRecruitingNCT066909831 country
- Semantic Rehabilitation for Patients With Primary Progressive Semantic AphasiaRecruitingNCT04957537Not applicable1 country
- Learning Amyloid and Tau ResultsEnrolling by invitationNCT072229301 country
- Study of Tau Imaging With the Use of [18F]MK-6240 TracerEnrolling by invitationNCT041046591 country
- Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative DiseasesRecruitingNCT075317321 country
- The Swedish BioFINDER 2 StudyRecruitingNCT03174938Not applicable1 country
- Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal DementiaRecruitingNCT06604520Phase 21 country
- Tau PET in Imaging and Cognition: Healthy Adults From 55-90RecruitingNCT033723171 country
- Incremental Diagnostic Value of Tau-PET With [18F]RO948 vs Amyloid-PET in Patients With Cognitive ImpairmentRecruitingNCT06618872Not applicable1 country
- Daridorexant for Alzheimer Disease PreventionRecruitingNCT07213349Phase 21 country
- Understanding Mechanisms of Synaptic Degeneration Underlying Clinical Symptoms in Patients With MDs and NDs.Enrolling by invitationNCT072348511 country
- Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related DisordersEnrolling by invitationNCT046801301 country
- Investigator Initiated Study for the Safety and Efficacy in Frontotemporal DementiaNot yet recruitingNCT07154485Phase 2
- Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.Enrolling by invitationNCT03389100Phase 21 country
- Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)Enrolling by invitationNCT059673901 country
- The Skin as a Window to the Central Nervous System in Frontotempolar Lombar DegenerationRecruitingNCT06490822Not applicable1 country
- BioFINDER-Brown: Examination of Alzheimer's Disease BiomarkersEnrolling by invitationNCT054579981 country
- A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolar Disorder: a Neuroimaging and Epigenetics Integrated ApproachRecruitingNCT06706687Not applicable1 country
- Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease DiagnosisRecruitingNCT050206261 country
- Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and EmotionsRecruitingNCT05165186Not applicable1 country
- Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition?RecruitingNCT059439251 country
- Multifactorial Approach to Dementia, Multicentric StudyRecruitingNCT059233071 country
- The Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)RecruitingNCT058852951 country
- Modifiable Variables in Parkinsonism (MVP)RecruitingNCT021948161 country
- A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 GenesTerminatedNCT04747431Phase 1/25 countries
- ECOCAPTURE for the Assessment of Apathy Under Real-life ConditionsCompletedNCT048651721 country
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolActive, not recruitingNCT035072576 countries
- Nabilone for Agitation in Frontotemporal DementiaTerminatedNCT05742698Phase 21 country
- Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)Active, not recruitingNCT05331144Phase 21 country
- First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the BrainCompletedNCT07348276Early Phase 11 country
- A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's DiseaseCompletedNCT05063539Phase 25 countries
- Tau PET Imaging in Opioid Use DisorderCompletedNCT05651516Early Phase 11 country
- Biology-Driven Cognitive Profiling in Huntington's DiseaseActive, not recruitingNCT075037431 country
- Alzheimer's Disease Neuroimaging Initiative 3CompletedNCT028540332 countries
- Voices Of Individuals: Challenges and Experiences Of bvFTDCompletedNCT040600821 country
- Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear PalsyCompletedNCT04539041Phase 14 countries
- Family Caregiver Online Survey (Dementia and Swallowing Difficulties)CompletedNCT064716601 country
- Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal DementiaCompletedNCT02736695Phase 11 country
- ETASCAI Pilot ProjectCompletedNCT06790849Not applicable1 country
- Lithium As a Treatment to Prevent Impairment of Cognition in EldersCompletedNCT03185208Phase 41 country
- Ectosomes, New Biomarkers of Tau Pathology?CompletedNCT033814821 country
- Alzheimer's PET Imaging in Racially/Ethnically Diverse AdultsCompletedNCT03706261Phase 11 country